XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
H.R.2356 "WMD Prevention and Preparedness Act of 2011," all provisions relating to biodefense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Defense DEF
Issues relating to biodefense and national security strategy. Issues pertaining to the reauthorization of P.L. 109-417 Pandemic and All Hazards Preparedness Act of 2006 and the reauthorization of P.L.108-276 Project Bioshield Act of 2004, provisions relating to biomedical countermeasure procurement strategy and process. H.R. 2405 "Pandemic and All-Hazards Preparedness Reauthorization Act of 2011," all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Copyright/Patent/Trademark CPT
S. 23 / H.R. 1249 America Invents Act, provisions specific to biotechnology intellectual property and patent applications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Budget/Appropriations BUD
Issues pertaining to 2012 appropriations for the Special Reserve Fund and the Public Health and Social Services Emergency Fund, the Food and Drug Administration, and the National Institutes of Health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.